PAL
Click for more information
0.00% 29.5¢ palla pharma limited

Ann: Palla 1H2019 Results Investor Presentation, page-2

  1. Eey Ore
    348 Posts.
    lightbulb Created with Sketch. 83
    clock Created with Sketch.
    29/08/19
    09:30
    Post #: 40211218
    The story just keeps getting better. Good work to the management team! Good long term outlook unless bought out short term.
    PAL Price at posting: $1.14 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

LU7 Lithium Universe inks final layout for Becancour lithium plant as DFS rolls on
right-arrow Created with Sketch.
I88 Infini boosts WA uranium holdings with Bellah Bore East acquisition
right-arrow Created with Sketch.
IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.